Commentary RE: “Efficacy and Safety of a Dual Inhibitor of 5-Alpha-Reductase Types 1 and 2 (Dutasteride) in Men With Benign Prostatic Hyperplasia”

Eric Kim; Gerald Andriole

doi:10.1016/j.urology.2020.04.019

Commentary RE: “Efficacy and Safety of a Dual Inhibitor of 5-Alpha-Reductase Types 1 and 2 (Dutasteride) in Men With Benign Prostatic Hyperplasia”

Eric Kim, Gerald Andriole

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	339-340
Number of pages	2
Journal	Urology
Volume	145
DOIs	https://doi.org/10.1016/j.urology.2020.04.019
State	Published - Nov 2020

Access to Document

10.1016/j.urology.2020.04.019

Cite this

@article{0a2cd9389ada47a3856bec344b9f3078,

title = "Commentary RE: “Efficacy and Safety of a Dual Inhibitor of 5-Alpha-Reductase Types 1 and 2 (Dutasteride) in Men With Benign Prostatic Hyperplasia”",

author = "Eric Kim and Gerald Andriole",

year = "2020",

month = nov,

doi = "10.1016/j.urology.2020.04.019",

language = "English",

volume = "145",

pages = "339--340",

journal = "Urology",

issn = "0090-4295",

}

TY - JOUR

T1 - Commentary RE

T2 - “Efficacy and Safety of a Dual Inhibitor of 5-Alpha-Reductase Types 1 and 2 (Dutasteride) in Men With Benign Prostatic Hyperplasia”

AU - Kim, Eric

AU - Andriole, Gerald

PY - 2020/11

Y1 - 2020/11

UR - http://www.scopus.com/inward/record.url?scp=85084822579&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2020.04.019

DO - 10.1016/j.urology.2020.04.019

M3 - Letter

C2 - 32304677

AN - SCOPUS:85084822579

SN - 0090-4295

VL - 145

SP - 339

EP - 340

JO - Urology

JF - Urology

ER -

Commentary RE: “Efficacy and Safety of a Dual Inhibitor of 5-Alpha-Reductase Types 1 and 2 (Dutasteride) in Men With Benign Prostatic Hyperplasia”

Access to Document

Other files and links

Cite this